Rejoinder: estimands and their estimators for clinical trials impacted by the COVID-19 pandemic: a report from the NISS ingram Olkin forum series on unplanned clinical trial disruptions

File(s)

Estimands_and_their_estimators_for_clinical_trials_impacted_by_COVID_19 (5).pdf (194.15 KB)

Accepted version

Show more

Author(s)

Van Lancker, Kelly

Tarima, Sergey

Bartlett, Jonathan

Bauer, Madeline

Bharani-Dharan, Bharani

more

Type

Journal Article

Date Issued

2023-01-02

Date Acceptance

2022-12-22

Citation

Statistics in Biopharmaceutical Research, 2023, 15 (1), pp.119-124

URI

http://hdl.handle.net/10044/1/103342

URL

https://www.tandfonline.com/doi/full/10.1080/19466315.2022.2162958

DOI

https://www.dx.doi.org/10.1080/19466315.2022.2162958

ISSN

1946-6315

Publisher

Taylor and Francis Group

Start Page

119

End Page

124

Journal / Book Title

Statistics in Biopharmaceutical Research

Volume

15

Issue

1

Copyright Statement

© 2023 American Statistical Association. This is an Accepted Manuscript of an article published by Taylor & Francis in
Statistics in Biopharmaceutical Research on 02 Jan 2023 available online: https://www.tandfonline.com/doi/full/10.1080/19466315.2022.2162958

Identifier

https://www.tandfonline.com/doi/full/10.1080/19466315.2022.2162958

Publication Status

Published

Date Publish Online

2023-02-07